ビジビリティスコア
100/100
AI言及数
7.3K
AI検索ボリューム
4.3M
2026年2月17日現在、Eli Lilly(lilly.com)のAIビジビリティスコアは 100中100(Google AI OverviewやChatGPTなどのプラットフォーム全体でのAI言及数合計7.3K件に基づく)となっています。同ブランドは4.3MのAI検索ボリュームを創出しています。 従来のSEO面において、Eli Lillyは推定で月間3.0M件のオーガニック訪問を獲得しており、トラフィック価値は$29.9Mに相当します。 ライフサイエンス分野の競合他社と比較して、Eli LillyはAI言及のシェア・オブ・ボイス(SoV)で5社中第2位に位置しています。
Eli Lilly and Company is a major American pharmaceutical company known for its diabetes treatments (including Mounjaro and Zepbound GLP-1 receptor agonists), oncology drugs, immunology therapies, and neuroscience pipeline. It is one of the fastest-growing pharma companies by market capitalization.
Eli Lillyは、トラッキング対象の2個のプラットフォーム全体で合計7.3K件のAI言及を獲得しており、4.3MのAI検索ボリュームを創出しています。 Google AI Overviewが言及数の86%を占め、最大のシェアを記録しています。 AIプラットフォームはEli Lillyを、Zepbound, Mounjaro, Eli Lilly and Companyを含む20個のブランドエンティティに関連付けています。
AIプラットフォームが回答内でEli Lillyを引用している質問のサンプル。
Zepbound (tirzepatide) is an FDA-approved prescription injectable medication for chronic weight management in adults with obesity or overweight with weight-related conditions, and also for adults with moderate-to-severe obstructive sleep apnea (OSA) . It works by mimicking natural hormones (GLP-1 and GIP) to reduce appetite, increase fullness, and slow stomach emptying, leading to less food intake and significant weight loss, alongside diet and exercise. Administered weekly, Zepbound has shown substantial weight reduction and improved OSA symptoms in clinical trials, but common side effects include nausea, diarrhea, and constipation, with rare serious risks like pancreatitis.12345
How it works
Cymbalta (generic name: duloxetine ) is a prescription medication classified as a serotonin-norepinephrine reuptake inhibitor (SNRI) . It is primarily used to treat mental health conditions like depression and anxiety, as well as chronic pain disorders.1234
Uses
Cymbalta is FDA-approved to treat the following conditions in adults:12
How It Works
Cymbalta works by increasing the levels of serotonin and norepinephrine in the brain and spinal cord. These neurotransmitters are responsible for regulating mood and decreasing pain signals.123
Side Effects
Common side effects of Cymbalta include:123
Serious Warnings:
Dosage
Important Considerations
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment.
The most common side effects of Mounjaro are gastrointestinal, including nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and stomach pain . Many of these digestive issues are mild to moderate and may diminish after a few weeks as the body adjusts to the medication. Less common but more serious side effects are also possible.
Common side effects
Eli Lilly and Company is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, that discovers, develops, and markets human pharmaceuticals.The company was founded in 1876 by Colonel Eli Lilly and focuses on therapeutic areas like oncology, diabetes, neuroscience, and immunology.Its products include well-known drugs like Trulicity, Mounjaro, and Verzenio.
Company overview
Therapeutic areas
Key products
Trulicity (dulaglutide) is a once-weekly injectable medication for adults and children (10+) with type 2 diabetes , used with diet and exercise to control blood sugar and reduce major heart problems (heart attack, stroke) in at-risk individuals, working by mimicking the GLP-1 hormone to boost insulin, slow digestion, and decrease appetite.Common side effects include nausea, diarrhea, vomiting, abdominal pain, and appetite decrease, but it carries a boxed warning for potential thyroid C-cell tumors (like MTC) and is contraindicated with a personal/family history of MTC or MEN 2. Patients inject it themselves under the skin, using a prefilled pen, and should monitor for serious signs like severe stomach pain, trouble swallowing, or signs of dehydration.
Uses
How it Works (Mechanism)
Administration
Side Effects & Warnings (Black Box Warning)
Eli Lillyは176.5K個のオーガニックキーワードでランクインしており、月間推定3.0M件の訪問を獲得し、そのトラフィック価値は$29.9Mに達しています。 トラッキング期間中、オーガニックトラフィックは5.3Mから6.8Mへと成長しました。 上位ランクインキーワードには「pharmacy near me」(順位:81位), 「pharmacy」(順位:66位), 「tirzepatide」(順位:1位)などが含まれます。
オーガニックトラフィック
3.0M
月間推定訪問数
オーガニックキーワード
176.5K
ランクインキーワード
トラフィック価値
$29.9M
月間推定価値
| キーワード | 順位 | 検索ボリューム |
|---|---|---|
| pharmacy near me | 81 | 2.2M |
| pharmacy | 66 | 1.5M |
| tirzepatide | 1 | 1.0M |
| tirzepatide | 2 | 1.0M |
| manjaro | 30 | 823.0K |
| mounjaro | 1 | 823.0K |
| zepbound | 1 | 823.0K |
| company's | 39 | 550.0K |
| dubai states | 74 | 550.0K |
| script express | 93 | 550.0K |
| covermymeds | 56 | 450.0K |
| duloxetine | 61 | 450.0K |
| duloxetine drugs | 75 | 450.0K |
| fluoxetine | 67 | 450.0K |
| s/a | 77 | 450.0K |
| jardiance | 8 | 368.0K |
| moore julianne | 65 | 368.0K |
| advi careers | 59 | 301.0K |
| brand mark usa | 77 | 301.0K |
| caremark cvs | 89 | 301.0K |
Eli Lillyは、競合5社の中でAI言及のシェア・オブ・ボイス第2位となっており、全言及数の18%を獲得しています。 Pfizerが24.2K件のAI言及で首位に立っています。 追跡対象の競合企業にはPfizer, Merck & Co., AbbVie, Novo Nordiskが含まれます。
| 企業 | 言及数 | AIボリューム |
|---|---|---|
| lilly.com (自社) | 6.2K | 4.3M |
| novonordisk.com (Novo Nordisk) | 475 | 268.5K |
| pfizer.com (Pfizer) | 24.2K | 18.7M |
| merck.com (Merck & Co.) | 2.3K | 1.4M |
| abbvie.com (AbbVie) | 1.4K | 533.0K |
これは静的なスナップショットです。継続的なAI可視化モニタリング、競合ベンチマーキング、そして引用フットプリントを向上させる根拠に基づいたGEOコンテンツは、VayoMedのDone-for-You成長エンジンに含まれています。